Epigenetic study provides new approaches to combination therapies for aggressive cancers

A recent study reveals how the interaction of the epigenetic protein BRD4 with the metabolic enzyme MTHFD1 controls gene expression and cell proliferation. The results of the study have now been published in the renowned journal Nature Genetics. They suggest novel approaches for the development of combination therapies for aggressive cancers.

from Health & Medicine News -- ScienceDaily http://bit.ly/2YOyvfA